NK cell MHC class I specific receptors (KIR): from biology to clinical intervention.
about
Interaction of a dengue virus NS1-derived peptide with the inhibitory receptor KIR3DL1 on natural killer cellsTargeting NK Cells for Anticancer Immunotherapy: Clinical and Preclinical ApproachesEffector Functions of Natural Killer Cell Subsets in the Control of Hematological MalignanciesMHC class I antigen processing and presenting machinery: organization, function, and defects in tumor cellsNK Cell Inflammation in the Clinical Outcome of Colorectal CarcinomaNK cell receptor imbalance and NK cell dysfunction in HBV infection and hepatocellular carcinomaKiller immunoglobulin-like receptors and tumor immunityCurrent perspectives on natural killer cell education and tolerance: emerging roles for inhibitory receptorsImmunological and Translational Aspects of NK Cell-Based Antitumor ImmunotherapiesSelection of an HLA-C*03:04-Restricted HIV-1 p24 Gag Sequence Variant Is Associated with Viral Escape from KIR2DL3+ Natural Killer Cells: Data from an Observational Cohort in South AfricaSwitch from protective to adverse inflammation during influenza: viral determinants and hemostasis are caught as culprits.Tetherin promotes the innate and adaptive cell-mediated immune response against retrovirus infection in vivo.Notch signaling at later stages of NK cell development enhances KIR expression and functional maturationBalancing natural killer cell activation through paired receptors.Present and Future of Allogeneic Natural Killer Cell TherapyHLA Class I Depleted hESC as a Source of Hypoimmunogenic Cells for Tissue Engineering Applications.Production of a Locus- and Allele-Specific Monoclonal Antibody for the Characterization of SLA-1*0401 mRNA and Protein Expression Levels in MHC-Defined MicrominipigsA good manufacturing practice method to ex vivo expand natural killer cells for clinical use.Tissue-Resident NK Cells Mediate Ischemic Kidney Injury and Are Not Depleted by Anti-Asialo-GM1 Antibody.The yin-yang of KIR3DL1/S1: molecular mechanisms and cellular function.Combination of human leukocyte antigen and killer cell immunoglobulin-like receptor genetic background influences the onset age of hepatocellular carcinoma in male patients with hepatitis B virus infection.Anti-KIR antibody enhancement of anti-lymphoma activity of natural killer cells as monotherapy and in combination with anti-CD20 antibodies.The biology of NK cells and their receptors affects clinical outcomes after hematopoietic cell transplantation (HCT).Comparative analysis of gingival tissue antigen presentation pathways in ageing and periodontitis.Functional NK cell repertoires are maintained through IL-2Rα and Fas ligand.Adaptive reconfiguration of the human NK-cell compartment in response to cytomegalovirus: a different perspective of the host-pathogen interaction.Type 1 diabetes therapy beyond T cell targeting: monocytes, B cells, and innate lymphocytesNatural killer cells in intracranial neoplasms: presence and therapeutic efficacy against brain tumoursAt the Bedside: Innate immunity as an immunotherapy tool for hematological malignancies.KIR and KIR ligand polymorphism: a new area for clinical applications?OX40 Agonists and Combination Immunotherapy: Putting the Pedal to the Metal.Generation of Potent T-cell Immunotherapy for Cancer Using DAP12-Based, Multichain, Chimeric ImmunoreceptorsNatural killer (NK) cells and anti-tumor therapeutic mAb: unexplored interactions.Human Leukocyte Antigen C*12:02:02 and Killer Immunoglobulin-Like Receptor 2DL5 are Distinctly Associated with Ankylosing Spondylitis in the Taiwanese.To serve and to protect: the role of decidual innate immune cells on human pregnancy.The immune system and cancer evasion strategies: therapeutic concepts.Killer Immunoglobulin-Like Receptor Allele Determination Using Next-Generation Sequencing TechnologyProspects of chimeric antigen receptor T-cell and natural killer cell therapies in acute leukemias.Uptake of CCR7 by KIR2DS4⁺ NK cells is induced upon recognition of certain HLA-C alleles.An overview of the potential strategies for NK cell-based immunotherapy for acute myeloid leukemia.
P2860
Q26314406-2ADEBEBC-07E7-49FA-8781-41AA27DBCA64Q26752518-57C7713D-06B1-4583-AE76-657D9363F619Q26776538-63DBCA58-5A90-49A0-9C87-F9D705618371Q26866479-09499741-0A96-4807-9B0B-26DBAD414A81Q26991949-6E6650E6-358D-45A7-A6EE-2075AD6E5E07Q27001052-A8CC613F-AE4C-446C-9442-EA78E53F9CA2Q27005792-13AFA67E-FC2D-4CD7-BA1A-352D77B133EFQ27009135-2FA53A98-B48A-4FA3-B763-666DAEAAD5C6Q28079180-D57E2A61-9A55-40C6-AFA3-05756D7DDEFBQ28607344-814FBCAF-CE95-4B99-B0D8-130D0B163084Q30354127-ED24F37A-C7C1-4159-AC2D-90AE74E02500Q34180302-71A1799E-3115-415D-98AF-94B8A0F00504Q34218967-D4D28F36-A518-497F-9FB5-3D7BA328CB73Q34465877-AC3522F0-3DA0-4C43-B211-FA21C97298DBQ35677351-FA1E88DD-8242-4405-84FE-A687AA963C91Q36160823-5705A18D-A4B1-4671-B34F-BD7D32CEAA38Q36167875-04E42804-79CB-42C2-8971-D8EFD7E07C2FQ36187369-7029A2C2-B876-489C-BDA9-72F1C86FE448Q36268854-25EDBC09-E7E4-4EDB-B7F7-F4823DABD757Q37090540-00DDA807-E5ED-4FAC-9B35-9A933C2AD26AQ37346665-AA0162D0-97D3-49B6-969D-E5B6DC852C0EQ37535232-D4FC3610-5A4A-49DD-9346-94513E2D6DC1Q37589671-8DEF63F7-7247-46D8-950F-D8FB9433CECAQ37632781-52039C8B-C305-48F3-9464-C350E05BA06CQ37692713-2F1C406A-8D9A-460B-A39C-B7E3B8E76EAEQ38095771-41F0A149-763D-4354-A83C-C10D106CD1E7Q38117282-9A25E652-6097-4421-8246-A3D2956308A5Q38148501-B10EDB62-8F44-4985-B5EB-72BE8A531726Q38149725-14E1D64E-6C47-4C2E-8E26-B531A07E93CCQ38185422-51B57904-8D2D-453C-B312-5891ED70BB98Q38374889-C97E8D66-42ED-4478-AFD2-FF253800D305Q38426341-0BAA3A69-A778-45BB-BA80-6B20BDF3DC47Q38542034-A92BD4BD-6879-412B-8621-5C9834201E3FQ38622369-9DB44CAF-EBF1-4B1E-8157-7F5D700A39FDQ38634374-7CFA2A12-C5B1-4B5C-AB8E-38410CCBDF1DQ38691172-82FFB695-34CC-4EDF-A186-F54254868EF5Q38744688-026AEC1C-29BA-4EC8-815B-DBBE03C905E5Q38859613-43520EF8-6715-4058-A7A1-4D7127962BDDQ38876802-EEC81215-84DD-40E3-B58C-87AE0AA8B000Q38930242-39E9003D-7E37-410B-901C-5646C2F699E4
P2860
NK cell MHC class I specific receptors (KIR): from biology to clinical intervention.
description
article científic
@ca
article scientifique
@fr
articol științific
@ro
articolo scientifico
@it
artigo científico
@gl
artigo científico
@pt
artigo científico
@pt-br
artikel ilmiah
@id
artikull shkencor
@sq
artículo científico
@es
name
NK cell MHC class I specific receptors (KIR): from biology to clinical intervention.
@en
NK cell MHC class I specific receptors
@nl
type
label
NK cell MHC class I specific receptors (KIR): from biology to clinical intervention.
@en
NK cell MHC class I specific receptors
@nl
prefLabel
NK cell MHC class I specific receptors (KIR): from biology to clinical intervention.
@en
NK cell MHC class I specific receptors
@nl
P1476
NK cell MHC class I specific receptors (KIR): from biology to clinical intervention.
@en
P2093
Ariane Thielens
François Romagné
P304
P356
10.1016/J.COI.2012.01.001
P50
P577
2012-01-20T00:00:00Z